Health department administers Emicizumab to treat severe Haemophilia A in Thrissur woman, marking a milestone in State's healthcare.
The Health department has started administering Emicizumab prophylaxis treatment to prevent bleeding episodes in a 32-year-old woman from Thrissur, who is suffering from congenital haemophilia A.
She is being treated at Thrissur Government Medical College, following detailed assessment of her condition and after counselling by a medical team.
Pfizer has received EC approval to expand the Hympavzi indication to treat haemophilia A or B with inhibitors in patients aged 12…
Approvato in Italia marstacimab per i casi severi senza inibitori dei fattori di coagulazione. La terapia, sottocutanea, è…
SCTIMST performs its first LDL apheresis for Familial Hypercholesterolemia, dramatically lowering cholesterol in a 34-year-old…
La prima somministrazione al Centro Emofilia del Policlinico di Milano. Come funziona e quali sono i risultati
Questa mattina, al Centro Emofilia del Policlinico di Milano, la prima terapia genica approvata per l'emofilia B (etranacogene…
Questa mattina, al Centro Emofilia del Policlinico di Milano, la prima terapia genica approvata per l'emofilia B (etranacogene…
